Global expansion Kuros Biosciences is Swiss-headquartered with operations in the Netherlands and the USA, indicating a global footprint and potential multi-region sales opportunities for their MagnetOs products and other orthobiologics.

MagnetOs momentum Recent commercial launches and demonstrations of MagnetOs MIS Delivery System, coupled with a Capital Markets Day focus on scalable quality growth, present a solid entry point for sales outreach to hospitals, clinics, and IDNs seeking advanced bone healing solutions.

Clinical leadership With extensive clinical and scientific advisory networks and multiple Level I trials initiated or completed, there is a strong evidence base to support adoption with key procurement and clinical decision makers in orthobiologics.

Financial health Revenue in the mid tens of millions and substantial funding raised suggest runway for scale, enabling targeted partnerships, larger pilot programs, and expanded distribution without immediate capital constraints.

Strategic partnerships A track record of presenting at major conferences, integrated delivery networks approvals, and ongoing investor communications signals openness to collaborations, licenses, and co-development opportunities in global orthopedic markets.